To protect plant health, Biotechnology Regulatory Services (BRS) implements APHIS regulations for certain organisms developed using genetic engineering that may pose a risk to plant health. APHIS coordinates these responsibilities along with the other designated federal agencies as part of the Federal Coordinated Framework for the Regulation of Biotechnology.
|11/9/22||USDA Seeks Public Input on Draft Environmental Documents for Deregulation of American Chestnut Developed Using Genetic Engineering|
|10/21/22||APHIS Issues Regulatory Status Review Responses: Infinite Enzymes, Inc., Corn and J.R. Simplot Potato|
|9/30/22||APHIS Issues Regulatory Status Review Responses: Agrivida, Inc. Corn and Toolgen, Inc. Potato|
|9/23/22||APHIS BRS Stakeholder Meeting – December 8 – Save the Date|
|9/6/22||APHIS Issues First Regulatory Status Review Response: Norfolk Plant Sciences’ Purple Tomato|
Learn about our biotechnology regulatory authority and the Coordinated Framework for Regulation of Biotechnology, which describes the federal system for evaluating products developed using biotechnology.
APHIS regulates the importation, interstate movement, or environmental release of certain organisms developed using genetic engineering that may pose a plant pest risk. Learn more about permitting requirements and our regulatory process.
BRS has a comprehensive system to help ensure that biotechnology organizations are maintaining compliance with APHIS’ biotechnology regulations.
The Biotechnology Quality Management Support (BQMS) Program helps biotechnology researchers and organizations analyze the critical control points within their management systems to help them better maintain compliance with APHIS regulations.